BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 27032982)

  • 1. Late endocrine effects of childhood cancer.
    Rose SR; Horne VE; Howell J; Lawson SA; Rutter MM; Trotman GE; Corathers SD
    Nat Rev Endocrinol; 2016 Jun; 12(6):319-36. PubMed ID: 27032982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine outcome in long-term survivors of childhood brain tumors.
    Shalitin S; Gal M; Goshen Y; Cohen I; Yaniv I; Phillip M
    Horm Res Paediatr; 2011; 76(2):113-22. PubMed ID: 21691048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma.
    Collet-Solberg PF; Sernyak H; Satin-Smith M; Katz LL; Sutton L; Molloy P; Moshang T
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):79-85. PubMed ID: 9302376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients.
    Maciel J; Dias D; Cavaco D; Donato S; Pereira MC; Simões-Pereira J
    J Endocrinol Invest; 2021 Nov; 44(11):2367-2374. PubMed ID: 33683662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late endocrine effects in pediatric central nervous system diseases.
    Aslan IR; Cheung CC
    J Pediatr Rehabil Med; 2014; 7(4):281-94. PubMed ID: 25547881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term and late treatment consequences: endocrine and metabolic effects.
    Han TS; Gleeson HK
    Curr Opin Support Palliat Care; 2017 Sep; 11(3):205-213. PubMed ID: 28661901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late endocrine effects of cancer and cancer therapies in survivors of childhood malignancies.
    Marques P; Van Huellen H; Fitzpatrick A; Druce M
    Minerva Endocrinol; 2016 Mar; 41(1):78-104. PubMed ID: 26365476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrinological late effects of oncologic treatment on survivors of medulloblastoma.
    Hidalgo Santos AD; de Mingo Alemany MDC; Moreno Macián F; León Cariñena S; Collado Ballesteros E; Cañete Nieto A
    Rev Chil Pediatr; 2019 Dec; 90(6):598-605. PubMed ID: 32186582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endocrine sequelae after treatment of pediatric cancer: From childhood to adulthood].
    Thomas-Teinturier C; Salenave S
    Bull Cancer; 2015; 102(7-8):612-21. PubMed ID: 25981322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late effects of treatment in survivors of childhood acute myeloid leukemia.
    Leung W; Hudson MM; Strickland DK; Phipps S; Srivastava DK; Ribeiro RC; Rubnitz JE; Sandlund JT; Kun LE; Bowman LC; Razzouk BI; Mathew P; Shearer P; Evans WE; Pui CH
    J Clin Oncol; 2000 Sep; 18(18):3273-9. PubMed ID: 10986060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic/endocrine disorders in survivors of childhood-onset and cranial radiotherapy- treated ALL/NHL: a meta-analysis.
    Zhang D; Gu M
    Reprod Biol Endocrinol; 2023 Oct; 21(1):91. PubMed ID: 37794442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes.
    van Iersel L; Li Z; Srivastava DK; Brinkman TM; Bjornard KL; Wilson CL; Green DM; Merchant TE; Pui CH; Howell RM; Smith SA; Armstrong GT; Hudson MM; Robison LL; Ness KK; Gajjar A; Krull KR; Sklar CA; van Santen HM; Chemaitilly W
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6101-6115. PubMed ID: 31373627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic and hypothalamic tumors of childhood: endocrine late effects.
    Oberfield SE; Garvin JH
    Pediatr Neurosurg; 2000 May; 32(5):264-71. PubMed ID: 10965274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study.
    Clement SC; Schouten-van Meeteren AY; Boot AM; Claahsen-van der Grinten HL; Granzen B; Sen Han K; Janssens GO; Michiels EM; van Trotsenburg AS; Vandertop WP; van Vuurden DG; Kremer LC; Caron HN; van Santen HM
    J Clin Oncol; 2016 Dec; 34(36):4362-4370. PubMed ID: 27998218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine late effects: manifestations and treatments.
    Fangusaro JR; Littlejohn EE
    Cancer Treat Res; 2009; 150():155-82. PubMed ID: 19834668
    [No Abstract]   [Full Text] [Related]  

  • 16. Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer.
    Gleeson HK; Darzy K; Shalet SM
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):335-48. PubMed ID: 12064896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late endocrine and growth sequelae after cancer treatment in children].
    Birkebaek NH; Helgestad JE
    Ugeskr Laeger; 1994 Aug; 156(32):4559-61, 4564-5. PubMed ID: 7832924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors.
    Shalitin S; Laur E; Lebenthal Y; Ash S; Yaniv I; Phillip M
    Horm Res Paediatr; 2014; 81(1):32-42. PubMed ID: 24246763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DIAGNOSING AND MONITORING ENDOCRINE DYSFUNCTION, DIABETES, AND OBESITY IN A COHORT OF ADULT SURVIVORS OF CHILDHOOD CANCER.
    Hudspeth VR; Gold SH; Clemmons DR
    Endocr Pract; 2017 Dec; 23(12):1394-1401. PubMed ID: 29144813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine consequences in young adult survivors of childhood cancer treatment].
    Leroy C; Cortet-Rudelli C; Desailloud R
    Ann Endocrinol (Paris); 2015 Oct; 76(6 Suppl 1):S29-38. PubMed ID: 26776287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.